Home | All trials

[RDF data]
Trial NCT00000355

Resource URI: http://static.linkedct.org/resource/trials/NCT00000355
PropertyValue
linkedct:brief_title Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/8837>
linkedct:condition <http://static.linkedct.org/resource/condition/12664>
linkedct:condition <http://static.linkedct.org/resource/condition/9249>
linkedct:criteria Please contact site for information.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 59 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000355
rdfs:label Trial NCT00000355
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/160264>
linkedct:nct_id NCT00000355
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Effects of Buprenophine and Naloxone in Opiate Addicts
linkedct:org_study_id NIDA-3-0012-4
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/8640>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000355>
linkedct:phase Phase 1
linkedct:secondary_id Y01-3-0012-4
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date November 1994
linkedct:study_design Treatment
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to evaluate the behavioral and physiological effects of buprenorphine and naloxone, both alone and in combination.
rdf:type linkedct:trials
linkedct:verification_date May 1995